The role of renal and liver function in clinical ctDNA testing.
Circulating tumor DNA (ctDNA) has high clinical potential in early cancer detection. The renal system and the liver are involved in clearing circulating cell free DNA (cfDNA) from the blood. Recent studies on mice show that inhibiting the liver's ability to clear cfDNA results in elevated ctDNA...
Saved in:
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2025-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://doi.org/10.1371/journal.pone.0319194 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849228178521849856 |
|---|---|
| author | Jens Bo Koudahl Conrad Tenna Vesterman Henriksen Jesper Berg Nors Mads Heilskov Rasmussen Mai-Britt Worm Ørntoft Nis Hallundbæk Schlesinger Per Vadgaard Andersen Kåre Andersson Gotschalck Claus Lindbjerg Andersen Claus Lindbjerg Andersen |
| author_facet | Jens Bo Koudahl Conrad Tenna Vesterman Henriksen Jesper Berg Nors Mads Heilskov Rasmussen Mai-Britt Worm Ørntoft Nis Hallundbæk Schlesinger Per Vadgaard Andersen Kåre Andersson Gotschalck Claus Lindbjerg Andersen Claus Lindbjerg Andersen |
| author_sort | Jens Bo Koudahl Conrad |
| collection | DOAJ |
| description | Circulating tumor DNA (ctDNA) has high clinical potential in early cancer detection. The renal system and the liver are involved in clearing circulating cell free DNA (cfDNA) from the blood. Recent studies on mice show that inhibiting the liver's ability to clear cfDNA results in elevated ctDNA levels in blood samples. Emphasizing the need for studies in humans exploring if markers of renal and liver function are associated with cfDNA and ctDNA levels in the blood. The present study investigates if cfDNA level, ctDNA level and ctDNA detection is affected in colorectal cancer (CRC) patients with clinical biomarkers indicative of low renal and liver function. We requisitioned standard laboratory tests of renal and liver function, measured within thirty days of curative intended surgery from 846 stage I-III CRC patients. For each patient, matching preoperative cfDNA and ctDNA data was available. We investigated the correlation between impaired renal and liver function and cfDNA level, ctDNA level, and ctDNA detection. The findings revealed that variation in renal and liver function in stage I-III CRC patients did not affect cfDNA level, ctDNA level, or ctDNA detection and that ctDNA test results remain stable over a wide range of renal and liver biomarker results. |
| format | Article |
| id | doaj-art-bc8ce730004440ee803efa365b5fdb9c |
| institution | Kabale University |
| issn | 1932-6203 |
| language | English |
| publishDate | 2025-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj-art-bc8ce730004440ee803efa365b5fdb9c2025-08-23T05:32:16ZengPublic Library of Science (PLoS)PLoS ONE1932-62032025-01-01202e031919410.1371/journal.pone.0319194The role of renal and liver function in clinical ctDNA testing.Jens Bo Koudahl ConradTenna Vesterman HenriksenJesper Berg NorsMads Heilskov RasmussenMai-Britt Worm ØrntoftNis Hallundbæk SchlesingerPer Vadgaard AndersenKåre Andersson GotschalckClaus Lindbjerg AndersenClaus Lindbjerg AndersenCirculating tumor DNA (ctDNA) has high clinical potential in early cancer detection. The renal system and the liver are involved in clearing circulating cell free DNA (cfDNA) from the blood. Recent studies on mice show that inhibiting the liver's ability to clear cfDNA results in elevated ctDNA levels in blood samples. Emphasizing the need for studies in humans exploring if markers of renal and liver function are associated with cfDNA and ctDNA levels in the blood. The present study investigates if cfDNA level, ctDNA level and ctDNA detection is affected in colorectal cancer (CRC) patients with clinical biomarkers indicative of low renal and liver function. We requisitioned standard laboratory tests of renal and liver function, measured within thirty days of curative intended surgery from 846 stage I-III CRC patients. For each patient, matching preoperative cfDNA and ctDNA data was available. We investigated the correlation between impaired renal and liver function and cfDNA level, ctDNA level, and ctDNA detection. The findings revealed that variation in renal and liver function in stage I-III CRC patients did not affect cfDNA level, ctDNA level, or ctDNA detection and that ctDNA test results remain stable over a wide range of renal and liver biomarker results.https://doi.org/10.1371/journal.pone.0319194 |
| spellingShingle | Jens Bo Koudahl Conrad Tenna Vesterman Henriksen Jesper Berg Nors Mads Heilskov Rasmussen Mai-Britt Worm Ørntoft Nis Hallundbæk Schlesinger Per Vadgaard Andersen Kåre Andersson Gotschalck Claus Lindbjerg Andersen Claus Lindbjerg Andersen The role of renal and liver function in clinical ctDNA testing. PLoS ONE |
| title | The role of renal and liver function in clinical ctDNA testing. |
| title_full | The role of renal and liver function in clinical ctDNA testing. |
| title_fullStr | The role of renal and liver function in clinical ctDNA testing. |
| title_full_unstemmed | The role of renal and liver function in clinical ctDNA testing. |
| title_short | The role of renal and liver function in clinical ctDNA testing. |
| title_sort | role of renal and liver function in clinical ctdna testing |
| url | https://doi.org/10.1371/journal.pone.0319194 |
| work_keys_str_mv | AT jensbokoudahlconrad theroleofrenalandliverfunctioninclinicalctdnatesting AT tennavestermanhenriksen theroleofrenalandliverfunctioninclinicalctdnatesting AT jesperbergnors theroleofrenalandliverfunctioninclinicalctdnatesting AT madsheilskovrasmussen theroleofrenalandliverfunctioninclinicalctdnatesting AT maibrittwormørntoft theroleofrenalandliverfunctioninclinicalctdnatesting AT nishallundbækschlesinger theroleofrenalandliverfunctioninclinicalctdnatesting AT pervadgaardandersen theroleofrenalandliverfunctioninclinicalctdnatesting AT kareanderssongotschalck theroleofrenalandliverfunctioninclinicalctdnatesting AT clauslindbjergandersen theroleofrenalandliverfunctioninclinicalctdnatesting AT clauslindbjergandersen theroleofrenalandliverfunctioninclinicalctdnatesting AT jensbokoudahlconrad roleofrenalandliverfunctioninclinicalctdnatesting AT tennavestermanhenriksen roleofrenalandliverfunctioninclinicalctdnatesting AT jesperbergnors roleofrenalandliverfunctioninclinicalctdnatesting AT madsheilskovrasmussen roleofrenalandliverfunctioninclinicalctdnatesting AT maibrittwormørntoft roleofrenalandliverfunctioninclinicalctdnatesting AT nishallundbækschlesinger roleofrenalandliverfunctioninclinicalctdnatesting AT pervadgaardandersen roleofrenalandliverfunctioninclinicalctdnatesting AT kareanderssongotschalck roleofrenalandliverfunctioninclinicalctdnatesting AT clauslindbjergandersen roleofrenalandliverfunctioninclinicalctdnatesting AT clauslindbjergandersen roleofrenalandliverfunctioninclinicalctdnatesting |